Netflix has now started testing its pricier ‘Ultra’ plan, with a possible $17-price tag. While it might raise many an eyebrow, this might be the final blow to cable companies, as it aims at a higher grade of cable cutters.
The new plan, which will be above it’s ‘Premium’ subscription, offers the same four simultaneous 4K streams at once. But it might get a new HDR video. According to CordCutting.com, the streaming giant is testing new plans in Germany, with both €16.99 and €19.99 price tags.
This also means that in the near future, if you want the most out of your Netflix, you might have to pay up more.
Forever, over-achiever
Last week, research firm Bernstein announced that it expects Netflix to achieve a subscriber base of 90 million in the US alone in less than 10 years, upbeating Netflix’s own estimate of 60 to 90 million subscribers for this period. Netflix now has about 57 million customers in its home market.
The predictions, that came after a survey done back in May, might seem far-fetched to many investors, but the research firm ensured its outlook by stating that pay-TV market reached its threshold at 100 million customers in the US.
RELATED: Netflix is almost THRICE as big as it was last year!
Last month, due to extreme optimism over the streaming giant, GBH Insights raised the price target to $500 from the previous target of $400. That time, the price target of $500 represented the highest, compared to the other price targets set by analysts covering the stock.
RELATED: Netflix price target raised to $500 from $400
RELATED: The rise of the streaming giant
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company